Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Opioid Induced Constipation (OIC) Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.5% during the forecast period.
This report presents the market size and development trends by detailing the Opioid Induced Constipation (OIC) Drugs market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Opioid Induced Constipation (OIC) Drugs market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Opioid Induced Constipation (OIC) Drugs industry and will help you to build a panoramic view of the industrial development.
Opioid Induced Constipation (OIC) Drugs Market, By Type:
Type 1
Type 2
Type 3
Opioid Induced Constipation (OIC) Drugs Market, By Application:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Some of the leading players are as follows:
Daewoong Pharmaceutical
Mundipharma International Limited
Ironwood Pharmaceuticals Inc
Valeant Pharmaceuticals International
Theravance Biopharma Inc
Takeda Pharmaceutical Company Limited
Purdue Pharma
Nektar Therapeutics
Allergan Plc
Daiichi Sankyo Co Ltd
Sucampo Pharmaceuticals
Cosmo Pharmaceuticals SA
Progenics Pharmaceuticals Inc
Pfizer
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Opioid Induced Constipation (OIC) Drugs Market: Technology Type Analysis
-
4.1 Opioid Induced Constipation (OIC) Drugs Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Opioid Induced Constipation (OIC) Drugs Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Type 1
4.3.2 Type 2
4.3.3 Type 3
5 Opioid Induced Constipation (OIC) Drugs Market: Product Analysis
-
5.1 Opioid Induced Constipation (OIC) Drugs Product Market Share Analysis, 2018 & 2026
-
5.2 Opioid Induced Constipation (OIC) Drugs Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Opioid Induced Constipation (OIC) Drugs Market: Application Analysis
-
6.1 Opioid Induced Constipation (OIC) Drugs Application Market Share Analysis, 2018 & 2026
-
6.2 Opioid Induced Constipation (OIC) Drugs Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Hospital Pharmacies
6.3.2 Retail Pharmacies
6.3.3 Online Pharmacies
7 Opioid Induced Constipation (OIC) Drugs Market: Regional Analysis
-
7.1 Opioid Induced Constipation (OIC) Drugs Regional Market Share Analysis, 2018 & 2026
-
7.2 Opioid Induced Constipation (OIC) Drugs Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Daewoong Pharmaceutical
9.1.1 Daewoong Pharmaceutical Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Mundipharma International Limited
9.2.1 Mundipharma International Limited Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Ironwood Pharmaceuticals Inc
9.3.1 Ironwood Pharmaceuticals Inc Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Valeant Pharmaceuticals International
9.4.1 Valeant Pharmaceuticals International Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Theravance Biopharma Inc
9.5.1 Theravance Biopharma Inc Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Takeda Pharmaceutical Company Limited
9.6.1 Takeda Pharmaceutical Company Limited Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Purdue Pharma
9.7.1 Purdue Pharma Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Nektar Therapeutics
9.8.1 Nektar Therapeutics Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Allergan Plc
9.9.1 Allergan Plc Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Daiichi Sankyo Co Ltd
9.10.1 Daiichi Sankyo Co Ltd Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Sucampo Pharmaceuticals
9.11.1 Sucampo Pharmaceuticals Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Cosmo Pharmaceuticals SA
9.12.1 Cosmo Pharmaceuticals SA Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Progenics Pharmaceuticals Inc
9.13.1 Progenics Pharmaceuticals Inc Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Pfizer
9.14.1 Pfizer Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
The List of Tables and Figures (Totals 66 Figures and 165 Tables)
Figure Type 1 Opioid Induced Constipation (OIC) Drugs market, 2015 - 2026 (USD Million)
Figure Type 2 Opioid Induced Constipation (OIC) Drugs market, 2015 - 2026 (USD Million)
Figure Type 3 Opioid Induced Constipation (OIC) Drugs market, 2015 - 2026 (USD Million)
Figure Hospital Pharmacies market, 2015 - 2026 (USD Million)
Figure Retail Pharmacies market, 2015 - 2026 (USD Million)
Figure Online Pharmacies market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Opioid Induced Constipation (OIC) Drugs market, by country, 2015 - 2026 (USD Million)
-
Table North America Opioid Induced Constipation (OIC) Drugs market, by type, 2015 - 2026 (USD Million)
-
Table North America Opioid Induced Constipation (OIC) Drugs market, by product, 2015 - 2026 (USD Million)
-
Table North America Opioid Induced Constipation (OIC) Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Opioid Induced Constipation (OIC) Drugs market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Opioid Induced Constipation (OIC) Drugs market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Opioid Induced Constipation (OIC) Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Opioid Induced Constipation (OIC) Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Canada Opioid Induced Constipation (OIC) Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Canada Opioid Induced Constipation (OIC) Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Europe Opioid Induced Constipation (OIC) Drugs market, by country, 2015 - 2026 (USD Million)
-
Table Europe Opioid Induced Constipation (OIC) Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Europe Opioid Induced Constipation (OIC) Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Europe Opioid Induced Constipation (OIC) Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Opioid Induced Constipation (OIC) Drugs market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Opioid Induced Constipation (OIC) Drugs market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Opioid Induced Constipation (OIC) Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Opioid Induced Constipation (OIC) Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Germany Opioid Induced Constipation (OIC) Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Germany Opioid Induced Constipation (OIC) Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Opioid Induced Constipation (OIC) Drugs market, by type, 2015 - 2026 (USD Million)
-
Table France Opioid Induced Constipation (OIC) Drugs market, by product, 2015 - 2026 (USD Million)
-
Table France Opioid Induced Constipation (OIC) Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Opioid Induced Constipation (OIC) Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Italy Opioid Induced Constipation (OIC) Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Italy Opioid Induced Constipation (OIC) Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Opioid Induced Constipation (OIC) Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Spain Opioid Induced Constipation (OIC) Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Spain Opioid Induced Constipation (OIC) Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Opioid Induced Constipation (OIC) Drugs market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Opioid Induced Constipation (OIC) Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Opioid Induced Constipation (OIC) Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Opioid Induced Constipation (OIC) Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Opioid Induced Constipation (OIC) Drugs market, by type, 2015 - 2026 (USD Million)
-
Table China Opioid Induced Constipation (OIC) Drugs market, by product, 2015 - 2026 (USD Million)
-
Table China Opioid Induced Constipation (OIC) Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Opioid Induced Constipation (OIC) Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Japan Opioid Induced Constipation (OIC) Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Japan Opioid Induced Constipation (OIC) Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Opioid Induced Constipation (OIC) Drugs market, by type, 2015 - 2026 (USD Million)
-
Table India Opioid Induced Constipation (OIC) Drugs market, by product, 2015 - 2026 (USD Million)
-
Table India Opioid Induced Constipation (OIC) Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Opioid Induced Constipation (OIC) Drugs market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Opioid Induced Constipation (OIC) Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Opioid Induced Constipation (OIC) Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Opioid Induced Constipation (OIC) Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Opioid Induced Constipation (OIC) Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Opioid Induced Constipation (OIC) Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Opioid Induced Constipation (OIC) Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Opioid Induced Constipation (OIC) Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Opioid Induced Constipation (OIC) Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Opioid Induced Constipation (OIC) Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Opioid Induced Constipation (OIC) Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Opioid Induced Constipation (OIC) Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Opioid Induced Constipation (OIC) Drugs market, by application, 2015 - 2026 (USD Million)
-
Table MEA Opioid Induced Constipation (OIC) Drugs market, by country, 2015 - 2026 (USD Million)
-
Table MEA Opioid Induced Constipation (OIC) Drugs market, by type, 2015 - 2026 (USD Million)
-
Table MEA Opioid Induced Constipation (OIC) Drugs market, by product, 2015 - 2026 (USD Million)
-
Table MEA Opioid Induced Constipation (OIC) Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Opioid Induced Constipation (OIC) Drugs market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Opioid Induced Constipation (OIC) Drugs market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Opioid Induced Constipation (OIC) Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Opioid Induced Constipation (OIC) Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Opioid Induced Constipation (OIC) Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Opioid Induced Constipation (OIC) Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Daewoong Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mundipharma International Limited Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Ironwood Pharmaceuticals Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Valeant Pharmaceuticals International Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Theravance Biopharma Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Takeda Pharmaceutical Company Limited Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Purdue Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Nektar Therapeutics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Allergan Plc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Daiichi Sankyo Co Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sucampo Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cosmo Pharmaceuticals SA Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Progenics Pharmaceuticals Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
